Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance. Combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases the likelihood of chemoresistance, making it essential to understand for multiple therapy options.
Breast --- Cancer --- Treatment. --- Triple Negative Breast Neoplasms --- Drug Therapy, Combination --- therapy
Choose an application
Choose an application
"Combination Drug Delivery Approach as an Effective Therapy for Various Diseases explores the use of bioengineering tools in combination drug delivery approaches to control various diseases at different clinical stages of synergistic action, varying mechanisms of action, and during the suppression of drug resistance. The book presents fundamental knowledge on the experiential and experimental aspects of drug combination approaches in order to equip rational applications in preventing the emergence of resistance during the treatment of various diseases. It provides a holistic understanding of the principles behind formation, characterization, applications, regulations, toxicity, challenges and future perspectives of combination drug delivery approaches."--
Drug delivery systems. --- Delivery systems, Drug --- Drug administration technology --- Drug delivery technology --- Drugs --- Pharmaceutical technology --- Delivery systems --- Chemotherapy. --- Chemotherapy, Combination. --- Drug resistance --- Drug Delivery Systems --- Drug Therapy, Combination --- Drug Synergism --- Drug Resistance --- Prevention.
Choose an application
Oncology. Neoplasms --- Drug Therapy --- Medicine, East Asian Traditional --- Diseases --- Medicine, Traditional --- Therapeutics --- Culture --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Complementary Therapies --- Anthropology, Cultural --- Anthropology --- Social Sciences --- Anthropology, Education, Sociology and Social Phenomena --- Medicine, Chinese Traditional --- Neoplasms --- Drug Therapy, Combination
Choose an application
Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer Therapy: Modulators and Potentiators, expert physician-scientists and clinicians with first-hand experience in the clinical development of targeted therapies review those combinations that hold the most promise for the future of medical oncology, detailing their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory benchtop to the patient's bedside as a new generation of cancer therapeutics. Cutting-edge and forward-looking, Combination Cancer Therapy: Modulators and Potentiators offers everyone in the fields of cancer drug development and therapy a powerful new understanding of the optimal sequencing and scheduling of new combination drug therapies necessary to maximize the effects for cancer patients today.
Neoplasms --- Drug Therapy, Combination. --- Cancer --- Apoptosis. --- Apoptose --- drug therapy. --- Chemotherapy. --- Treatment. --- Chimiothérapie --- Traitement --- Apoptosis --- Drug Therapy, Combination --- Chemotherapy --- Treatment --- drug therapy --- Cancer -- Chemotherapy. --- Cancer -- Treatment. --- Drug Therapy --- Therapeutics --- Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer therapy --- Cancer treatment --- Therapy --- Medicine. --- Oncology. --- Medicine & Public Health. --- Tumors --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Cell death --- Antineoplastic agents --- Oncology . --- Cancer - Chemotherapy --- Cancer - Treatment --- Neoplasms - drug therapy
Choose an application
Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia, and includes discussion of future therapies that are currently in late stages of clinical evaluation. Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia. Statins remain the mainstay of drug therapy for hyperlipidemia and chapters in this book specifically examine the role of add-on therapy with different agents modulating the different lipid fractions in the blood, e.g. bile acid sequestrants, fibric acid derivatives (fibrates), omega-3 fatty acids (fish oils), inhibitors of Niemann-Pick C1 like 1 (NPC1L1) protein, cholesteryl ester transfer protein (CETP), apolipoprotein B-100 and microsomal triglyceride transfer protein (MTP), and the emerging proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. There is additional discussion of the role of non-drug therapy options such as nutraceuticals, functional foods and lipoprotein apheresis. The book also discusses the combination of antihypertensive drugs with lipid-lowering drugs in the management of cardiovascular risk in patents with dyslipidemia.
Medicine & Public Health. --- Cardiology. --- Pharmacotherapy. --- Pharmacology/Toxicology. --- Medicine. --- Toxicology. --- Médecine --- Toxicologie --- Cardiologie --- Chemotherapy, Combination. --- Dyslipoproteinemias. --- Hyperlipidemia. --- Medicine --- Health & Biological Sciences --- Cardiovascular Diseases --- Combination chemotherapy --- Combination drug therapy --- Drug therapy, Combination --- Polychemotherapy --- Hyperlipemia --- Hyperlipidaemia --- Pharmacology. --- Blood lipoproteins --- Blood lipids --- Lipids --- Metabolism --- Disorders --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Heart --- Internal medicine --- Toxicology --- Diseases --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Drug therapy --- Pharmacotherapy --- Therapeutics --- Physiological effect
Choose an application
Liver disease has been identified as a leading cause of death in HIV-infected patients since the introduction of highly active antiretroviral therapy (HAART) in 1996. The HIV treatment community has been caught largely unaware of this emerging dilemma. Many HIV care providers are ill-equipped to understand and interpret liver injury patterns, or to provide comprehensive care and management for viral coinfections which they are not familiar with. HIV and Liver Disease provides a comprehensive update of the field covering the epidemiology, pathogenesis, management and treatment of liver disease in patients with HIV infection. The volume will help HIV care providers understand and interpret liver injury patterns, and/or provide comprehensive care and management for viral coinfections. Gastroenterologists and hepatologists will gain an understanding of complex drug regimens that are used to treat HIV and which may impact HCV and HBV treatment. Written by expert clinicians and researchers across multiple disciplines, HIV and Liver Disease will be of great value to gastroenterologists, hepatologists, infectious disease practitioners, as well as other health care providers who provide care or participate in research in the field of HIV.
HIV infections -- Complications. --- HIV infections. --- Liver -- Diseases. --- Liver --- HIV infections --- Virus Diseases --- Sexually Transmitted Diseases, Viral --- Drug Therapy, Combination --- Digestive System Diseases --- Hepatitis --- Immunologic Deficiency Syndromes --- Lentivirus Infections --- Drug Therapy --- Diseases --- Retroviridae Infections --- Immune System Diseases --- Sexually Transmitted Diseases --- Therapeutics --- RNA Virus Infections --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Hepatitis, Viral, Human --- HIV Infections --- Liver Diseases --- Antiretroviral Therapy, Highly Active --- Medicine --- Health & Biological Sciences --- Gastroenterology --- Complications --- Diseases. --- HIV (Viruses) infections --- HTLV-III infections --- HTLV-III-LAV infections --- Human T-lymphotropic virus III infections --- Medicine. --- Internal medicine. --- Gastroenterology. --- Hepatology. --- Medicine & Public Health. --- Internal Medicine. --- Lentivirus infections --- Sexually transmitted diseases --- Clinical medicine. --- Medicine, Internal --- Medicine, Clinical --- Internal medicine --- Digestive organs --- Gastroenterology .
Choose an application
Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.
Ovarian diiseases -- Therapy. --- Ovarian diseases -- Diagnosis. --- Ovaries -- Diseases. --- Ovaries --- Antineoplastic Protocols --- Therapeutics --- Ovarian Diseases --- Genital Neoplasms, Female --- Endocrine Gland Neoplasms --- Drug Administration Routes --- Drug Therapy, Combination --- Neoplasms by Site --- Gonadal Disorders --- Clinical Protocols --- Urogenital Neoplasms --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Endocrine System Diseases --- Adnexal Diseases --- Ovarian Neoplasms --- Infusions, Parenteral --- Antineoplastic Combined Chemotherapy Protocols --- Drug Therapy --- Neoplasms --- Female Urogenital Diseases --- Diseases --- Genital Diseases, Female --- Female Urogenital Diseases and Pregnancy Complications --- Medicine --- Health & Biological Sciences --- Oncology --- Cancer --- Surgery. --- Treatment. --- Medicine. --- Oncology. --- Medicine & Public Health. --- Oncology . --- Tumors
Choose an application
Induction chemotherapy, as part of an integrated plan of management for locally advanced cancers, is being practised throughout the world in independent, isolated departments in universities, teaching hospitals, and clinical schools. Frequently, however, teams are relatively unaware of the work being undertaken in other institutions, and this situation may slow further progress. This book aims to present the full range of management techniques and practices used in induction chemotherapy within one accessible volume. It provides up-to-date information on the pioneering and cutting edge practices employed in different institutions and documents the advantages of integrated treatment schedules. Patient selection is discussed, and each of the cancer types for which induction therapy has proved important is considered in detail. All who are responsible for the treatment of patients with locally advanced cancers will find this book to be an invaluable source of information. It will be particularly interesting for specialist oncologists aiming to set up and develop fully comprehensive cancer centres and for health administrators wishing to learn about the benefits of establishing such centres in strategic locations.
Cancer -- Chemotherapy. --- Cancer -- Treatment. --- Chemotherapy. --- Infusions, Parenteral --- Therapeutic Uses --- Diseases --- Therapeutics --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Drug Administration Routes --- Pharmacologic Actions --- Drug Therapy --- Chemical Actions and Uses --- Chemicals and Drugs --- Infusions, Intra-Arterial --- Remission Induction --- Neoplasms --- Antineoplastic Agents --- Medicine --- Health & Biological Sciences --- Oncology --- Chemotherapy, Combination. --- Cancer --- Drug therapy --- Pharmacotherapy --- Combination chemotherapy --- Combination drug therapy --- Drug therapy, Combination --- Polychemotherapy --- Medicine. --- General practice (Medicine). --- Oncology. --- Medicine & Public Health. --- General Practice / Family Medicine. --- Antineoplastic agents --- Drugs --- Pharmacology --- Treatment --- Oncology . --- Family medicine. --- Family practice (Medicine) --- General practice (Medicine) --- Physicians (General practice) --- Tumors
Choose an application
In human solid tumors, nodal status is the most important prognostic indicator for patient outcome. Recent developments in the sentinel lymph node concept have resulted in new procedures to define the first draining node as the primary gateway through which the cancer will spread. In From Local Invasion to Metastatic Cancer: Involvement of Distant Sites Through the Lymphovascular System, a panel of international authorities takes an in-depth look at the role of the lymphovascular system in the spread of cancer. The authors summarize the findings of the Second International Symposium on Cancer Metastasis: Basis for Rational Therapy summit. Specifically, the book presents important developments in the biology and clinical understanding of cancer metastasis, describes the relationship between tumor microenvironment and proliferation, and defines the process of lymphangiogenesis and angiogenesis with special reference to cancer metastasis. From Local Invasion to Metastatic Cancer: Involvement of Distant Sites Through the Lymphovascular System provides oncologists, radiologists, and cancer researchers the necessary information to study and develop new strategies to curb the process of metastasis.
Lymphatic Metastasis -- Congresses. --- Metastasis. --- Oncology --- Medicine --- Health & Biological Sciences --- Metastasis --- Lymphangiogenesis --- Congresses --- Neovascularization, Pathologic --- Neoplasm Invasiveness --- Antineoplastic Combined Chemotherapy Protocols --- Lymphatic Metastasis --- Organogenesis --- Neoplasm Metastasis --- Publication Formats --- Antineoplastic Protocols --- Neoplastic Processes --- Metaplasia --- Drug Therapy, Combination --- Pathologic Processes --- Embryonic and Fetal Development --- Clinical Protocols --- Publication Characteristics --- Neoplasms --- Drug Therapy --- Morphogenesis --- Therapeutics --- Pathological Conditions, Signs and Symptoms --- Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Growth and Development --- Physiological Processes --- Physiological Phenomena --- Phenomena and Processes --- Lymphatic metastasis. --- Oncology. --- Medicine. --- Radiotherapy. --- Pathology. --- Surgical oncology. --- Medicine & Public Health. --- Surgical Oncology. --- Tumors --- Lymphatics --- Cancer --- Oncology . --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Radiation therapy --- Electrotherapeutics --- Hospitals --- Medical electronics --- Medical radiology --- Therapeutics, Physiological --- Phototherapy --- Oncologic surgery --- Oncological surgery --- Surgical oncology --- Radiological services --- Excision --- Treatment --- Cancer metastasis --- Lymphovascular system
Listing 1 - 10 of 13 | << page >> |
Sort by
|